Overview of Prosthetic Heart Valve MarketThe Global Prosthetic Heart Valve Market is valued at USD 8.74 Billion in 2024 and ...

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter aortic valve replacement (TAVR) had similar rates of death or disabling ...

TCT 924: Valve in Valve Transcatheter Versus Redo Surgical Replacement of a Failing Bioprosthetic Aortic Valve: An Updated Systematic Review and Meta-Analysis ...

TCT 760: Valve In Valve Transcatheter Versus Redo Surgical Replacement of a Failing Bioprosthetic Aortic Valve: An Updated Meta-Analysis of Echocardiographic and Long-Term Outcomes ...

Medtronic, the global leader in healthcare technology, today announced new data from the largest head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR), the ...

Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of blood clots, according to a ...

Abbott announced the FDA has approved its next-generation stented bioprosthetic surgical valves for the treatment of aortic or mitral valve disease. According to a company press release, the ...

During the introduction of transcatheter aortic-valve replacement (TAVR) in the United States, requirements regarding procedural volume were mandated by the Centers for Medicare and Medicaid Servic ...

Scientists have developed a novel technique that prevents coronary artery obstruction during transcatheter aortic valve replacement (TAVR), a rare but often fatal complication. The method, called ...

To the Editor: Leon and colleagues (April 28 issue)1 report the results of the Placement of Aortic Transcatheter Valves (PARTNER) 2 cohort A randomized trial. They indicate that 2-year rates of dea ...